We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance: Agency to Accept More Discussion in Interactive Review
Guidance: Agency to Accept More Discussion in Interactive Review
March 8, 2013
The FDA will handle more serious concerns about premarket submissions during the interactive review process than initially planned, new draft guidance on FDA-industry communications during the submission process states.